Navigation Links
ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Date:3/12/2008

Forward Looking Statements

ADVENTRX cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: the potential for ADVENTRX's product candidates to receive regulatory approval for one or more indications on a timely basis or at all, and the uncertain process of seeking regulatory approval; difficulties or delays in developing, testing, manufacturing and marketing of and obtaining regulatory approval for ADVENTRX's product candidates; the market potential for ADVENTRX's product candidates and ADVENTRX's and any future partners' ability to compete in those markets; unexpected adverse side effects or inadequate therapeutic efficacy of ADVENTRX's product candidates that could delay or prevent regulatory approval or commercialization; the risk that preclinical and clinical results are not indicative of the success of subsequent clinical trials and that products will not perform as preclinical and clinical data suggests or as otherwise anticipated; the risk that ADVENTRX will be unable to raise sufficient capital to fund the projects necessary to meet its anticipated or stated goals and milestones; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date when made. ADVENTRX does not intend to update any forward-looking statement
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
2. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. Genzyme Announces Presentation of New Positive Data on Carticel(R)
7. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
8. Oral Talactoferrin Alfa Improves Overall Survival in Patients With Refractory Non-Small Cell Lung Cancer: Final Phase 2 Study Results Presented at the 8th Annual Targeted Therapies for the Treatment Of Lung Cancer Meeting
9. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
11. Intra-Cellular Therapies Presents Data on Its Schizophrenia and Cognition in Schizophrenia Programs at the 14th Biennial Winter Workshop on Schizophrenia and Bipolar Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MISSISSAUGA, ON , May 29, 2015 /CNW/ ... COV), an advanced medical technologies company, is delighted ... quarter ended March 31, 2015, which includes revenue ... for the quarter of $264,340. Revenue from advanced wound ... ended March 31, 2015 increased 24% to $1,742,672 ...
(Date:5/29/2015)... OAKS, Calif. , May 29, 2015 /PRNewswire/ ... pooled data from two pivotal Phase 3, global, ... calcimimetic, for the treatment of secondary hyperparathyroidism (SHPT) ... hemodialysis. Both studies met the primary endpoint, demonstrating ... AMG 416 groups achieved a greater than 30 ...
(Date:5/28/2015)... HOUSTON , May 28, 2015 /PRNewswire/ - ESSA Pharma ... results for the second quarter and three and six months ... in Canadian dollars and in accordance with International Financial Reporting ... ESSA recorded a net loss of $5.9 million ($0.35 per ... (Q2-2015), compared to a net loss of $0.4 million ($0.03 ...
Breaking Medicine Technology:Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 2Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 3Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 4Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 5Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 6Amgen Presents Pooled Phase 3 AMG 416 Data For The Treatment Of Secondary Hyperparathyroidism In Patients With Chronic Kidney Disease 7Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 2Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 3Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 4Essa Pharma Inc. Reports Second Quarter 2015 Financial Results 5
... MOUNTAIN VIEW, Calif., April 4, 2011 VIVUS, Inc. (Nasdaq: ... patients treated with the investigational drug QNEXA® for two years ... medications as well as improvements in lipid levels following significant ... placebo group over two years. The data ...
... community pharmacy chain, has revealed that one in four* (24%) of ... has taken or applied medicines which they later discovered were out ... (53%) of people do not always check the expiry date of ... This is worrying considering that nearly one in ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3
(Date:5/29/2015)... Astoria, NY (PRWEB) May 29, 2015 Thursday, ... United States. People from all walks of life came ... , Because Red Nose Day is a campaign dedicated to ... by simply having fun and making people laugh, the people ... their clinic in Astoria. Here they provided food, fun ...
(Date:5/29/2015)... Acoustiblok recently resolved a noisy well motor issue ... Municipal Water District (Three Valleys MWD) in California. Ben ... project said, “The new Acoustiblok All Weather Sound Panels ... better looking than the temporary barriers. We are pleased ... the process, and the customer service was great.” , ...
(Date:5/29/2015)... May 29, 2015 New England ... the Clinical Proteomic Tumor Analysis Consortium (CPTAC) and ... a new product line of peptide stable isotope ... Tryptides™, or isotope labeled tryptic peptides, offers thousands ... and is now readily accessible to the biomedical ...
(Date:5/29/2015)... On May 28th, TheCelebrityDresses.com released their new range ... dresses. Most of the styles in their new collection ... than 80 styles of sexy cocktail dresses and 100 ... elements coming with the new release are color blocks, ... Many of the new styles are made of carefully ...
(Date:5/28/2015)... Kentucky (PRWEB) May 29, 2015 On Monday, ... its newest location at 160 Frankfort Road in Shelbyville, Kentucky ... oversee all operations as well as treat patients , ... provide a more convenient , local clinic to better serve ... patients first making their experience as trouble-free as possible by ...
Breaking Medicine News(10 mins):Health News:Groups, such as Hands-On Physical Therapy, Across the Country, Host Their Own Events and Make the Inaugural Red Nose Day a Huge Success 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 2Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 3Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 4Health News:Acoustiblok® Quiets Well Motor Noise for California Water District 5Health News:New England Peptide Announces New Tryptides™ Catalog 2Health News:New England Peptide Announces New Tryptides™ Catalog 3Health News:TheCelebrityDresses.com Released New Collection of Cheap Bridesmaid and Party Dresses 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3
... of health care reform in the U.S. Senate is one historic ... will make to every person living in this country: If you ... to afford coverage and insurance companies will not run roughshod over ... include final passage after conference committee, effective implementation in the years ...
... embryonic-like cells, study finds , THURSDAY, Dec. 24 (HealthDay News) ... common cold and heal wounds, but the antioxidant might have ... stem cells, new research suggests. , The findings, published ... , add to previous research that showed how adult cells ...
... Dec. 24 The U.S. Senate bill,s historic expansion of ... of the health care system to the medical and insurance ... and state governments to monitor and police these industries and ... While the legislation requires every American to buy coverage under ...
... Speaker Nancy Pelosi issued the following statement this morning ... health insurance reform legislation: , "Today,s vote in ... affordable health insurance to every American. I commend Senator Reid ... a critical step on behalf of the health and security ...
... , WASHINGTON, Dec. 24 The following statement ... Association: , "Today, the Senate took an historic vote ... to millions of Americans and strengthening the private insurance market ... The AMA supported passage of the bill because it contains ...
... FOUNTAIN VALLEY, Calif., Dec. 24 Today Zealous, Inc. (OTC ... stake in Zealous Interactive in order to monetize the valued ... Gottlieb said, "We are in detailed talks with a major ... marketing assets owned by Zealous Interactive, a wholly owned subsidiary ...
Cached Medicine News:Health News:A Promise to Keep. Senate Vote is the First Step Toward the Promise of Quality, Affordable Health Care for All 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 2Health News:Historic Expansion of Health Insurance Coverage Cedes Control to Medical/Insurance Industries 3Health News:AMA: Senate Bill Passage Historic, More Work to Do in Conference 2Health News:Zealous in Talks to Sell Its Interactive Subsidiary; Company Said to be Considering All Options. 2
This table has an adjustable height, two legs, and square post. Clamps and standard 1" (2.5 cm) pad included....
... This table is designed ... in many procedures, allowing for ... auxiliary leg is stored onboard ... Post brackets quickly slide ...
Built-in accessory rail clamps quickly mount to any standard O.R. table or stretcher. The leg, available in single post or double tee adjusts with a simple twist. Optional armrests are available. Wal...
Light weight, clear imaging, attaches easily, perfect size, optional leg, table cart....
Medicine Products: